Abel Hall LLC Buys New Position in HealthEquity, Inc. $HQY

Abel Hall LLC bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 5,694 shares of the company’s stock, valued at approximately $476,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Acumen Wealth Advisors LLC acquired a new stake in shares of HealthEquity in the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd increased its stake in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares during the period. Leonteq Securities AG increased its stake in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares during the period. Finally, Torren Management LLC bought a new stake in HealthEquity during the fourth quarter worth approximately $40,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Price Performance

NASDAQ HQY opened at $96.57 on Tuesday. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $105.96. The business’s fifty day moving average is $86.41 and its two-hundred day moving average is $84.60. The stock has a market capitalization of $8.07 billion, a P/E ratio of 36.17, a P/E/G ratio of 1.60 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, research analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on HQY shares. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research report on Monday, June 1st. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday. Citigroup restated a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. JPMorgan Chase & Co. decreased their target price on HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research note on Wednesday, March 18th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.57.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 13,081 shares of company stock worth $1,193,000 in the last quarter. 1.60% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.